← FDA DRUG APPROVALS

FDA ANDA · ANDA203484

BUTALBITAL AND ACETAMINOPHEN

Sponsor: PHARMOBEDIENT

APPLICATION
ANDA203484
TYPE
ANDA
ORIGINAL APPROVAL
2015-12-04
LATEST ACTION
2015-12-04
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

ALLZITALPrescription
ACETAMINOPHEN 325MG, BUTALBITAL 25MG · TABLET · ORAL
BUTALBITAL AND ACETAMINOPHENPrescription
ACETAMINOPHEN 325MG, BUTALBITAL 50MG · TABLET · ORAL

Approval history

2015-12-04UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →